Compare BCRX & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | CDRE |
|---|---|---|
| Founded | 1986 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 1995 | 2021 |
| Metric | BCRX | CDRE |
|---|---|---|
| Price | $8.41 | $34.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $20.82 | ★ $39.67 |
| AVG Volume (30 Days) | ★ 4.2M | 199.0K |
| Earning Date | 05-15-2026 | 06-15-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ 381.40 | 13.33 |
| EPS | ★ 1.21 | 1.02 |
| Revenue | $25,186,000.00 | ★ $610,308,000.00 |
| Revenue This Year | N/A | $21.80 |
| Revenue Next Year | $12.55 | $4.51 |
| P/E Ratio | ★ $7.23 | $52.03 |
| Revenue Growth | N/A | ★ 7.53 |
| 52 Week Low | $6.00 | $27.07 |
| 52 Week High | $11.31 | $48.76 |
| Indicator | BCRX | CDRE |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 27.33 |
| Support Level | $7.95 | $31.58 |
| Resistance Level | $8.68 | $44.98 |
| Average True Range (ATR) | 0.31 | 2.45 |
| MACD | 0.05 | -0.78 |
| Stochastic Oscillator | 70.43 | 2.53 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.